Alliance Statement on ACS CAN Utilization Management Delays Survey

By proton-admin | March 28, 2019

Today, the American Cancer Society Cancer Action Network (ACS CAN) released a nationwide survey that demonstrates the widespread impacts insurance delays can have on patients, their families, and their doctors battling cancer.

Below is a statement from Daniel E. Smith, Executive Director of the Alliance for Proton Therapy Access:

The survey released by ACS CAN is a powerful reminder of the heavy emotional and financial burden many cancer patients endure while fighting their insurers for doctor-recommended cancer treatment. It shows that one in four cancer patients is frequently unable to access the treatment they need because of a decision by their insurer. Unsurprisingly, the survey shows delays and denials are causing cancer patients increased stress, frustration, and worry — all of which have a negative impact on patient health.

It’s time for Congress to hold insurers accountable for providing a fair and prompt review process to cancer patients facing a life-threatening illness. The principles outlined in our Cancer Patients’ Timely Treatment Bill of Rights provide a framework that Congress can adopt to balance the scales between patients and insurers.

 

###